Scientific guidance on post-authorisation efficacy studies

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMA/PDCO/CAT/CMDh/PRAC/CHMP/261500/2015
Published22/12/2015
Effective from01/06/2017
KeywordsPost-authorisation efficacy studies (PAES), efficacy, observational, randomised, trials pragmatic, explanatory, historical controls
DescriptionThis guidance has been developed in accordance with Article 108a of Directive 2001/83/EC which provides a mandate for European Medicines Agency (EMA) in cooperation with competent authorities and other interested parties to draw up scientific guidance on PAES.


Document history

First version
Current version
 

 

Adopted guideline

 

Overview of comments

 

Draft guideline

In operation: 01/06/2017-present

 

Published: 20/12/2016

 

Published: 06/11/2015


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more